Nucleotide receptors control IL-8/CXCL8 and MCP-1/CCL2 secretions as well as proliferation in human glioma cells

作者：Braganhol Elizandra; Kukulski Filip; Levesque Sebastien A; Fausther Michel; Lavoie Elise G; Zanotto Filho Alfeu; Bergamin Leticia S; Pelletier Julie; Bahrami Fariborz; Ben Yebdri Fethia; Fonseca Moreira Jose Claudio; Battastini Ana Maria O^*; Sevigny Jean

来源：Biochimica et Biophysica Acta-Molecular Basis of Disease, 2015, 1852(1): 120-130.

DOI：10.1016/j.bbadis.2014.10.014

• Glioma
• ATP
• P2 receptor
• IL-8/CXCL8
• MCP-1/CCL2

Glioma cells release cytokines to stimulate inflammation that facilitates cell proliferation. Here, we show that Lipopolysaccharide (LPS) treatment could induce glioma cells to proliferate and this process was dependent on nucleotide receptor activation as well as interleukin-8 (IL-8/CXCL8) secretion. We observed that extracellular nucleotides controlled IL-8/CXCL8 and monocyte chemoattractant protein 1 (MCP-1/CCL2) release by U251MG and U87MG human glioma cell lines via P2X7 and P2Y(6) receptor activation. The LPS-induced release of these cytokines was also modulated by purinergic receptor activation since IL-8 and MCP-1 release was decreased by the nucleotide scavenger apyrase as well as by the pharmacological P2Y(6) receptor antagonists suramin and MRS2578. In agreement with these observations, the knockdown of P2Y(6) expression decreased LPS-induced IL-8 release as well as the spontaneous release of IL-8 and MCP-1, suggesting an endogenous basal release of nucleotides. Moreover, high millimolar concentrations of ATP increased IL-8 and MCP-1 release by the glioma cells stimulated with suboptimal LPS concentration which were blocked by P2X7 and P2Y(6) antagonists. Altogether, these data suggest that extracellular nucleotides control glioma growth via P2 receptor-dependent IL-8 and MCP-1 secretions.

• 出版日期2015-1